U.S. market Closed. Opens in 16 hours 48 minutes

SANA | Sana Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue30.86M27.73M17.91M10.17M3.92M
Gross Profit-30.86M-27.73M-17.91M-10.17M-3.92M
Operating Expenses294.94M272.56M356.91M286.15M141.15M
Selling, General & Admin73.30M71.56M50.41M28.27M21.78M
Research & Development221.64M201.00M306.50M257.88M119.38M
Other Operating ExpensesN/A-674.00K305.00K97.00K-29.00K
Operating Income-325.81M-272.56M-356.91M-286.15M-141.15M
Other Expenses / Income42.55M3.09M981.00K844.00K2.83M
Before Tax Income-283.25M-269.48M-355.93M-285.31M-138.32M
Income Tax ExpensesN/A-3.09M-11.75M-6.67M-7.55M
Net Income-283.25M-266.39M-344.18M-278.64M-130.78M
Interest ExpensesN/A-15.62MN/AN/AN/A
Basic Shares Outstanding194.54M188.34M166.43M187.51M187.34M
Diluted Shares Outstanding194.54M188.34M166.43M187.51M187.34M
EBITDA-294.94M-272.56M-356.91M-286.15M-139.33M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-283.25M-285.10M-355.93M-285.31M-138.32M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙